Unique pharmacological properties of etrasimod among S1P receptor modulators

Unique pharmacological properties of etrasimod among S1P receptor modulators

Etrasimod (ADP334) is an oral, once‐daily, selective sphingosine 1‐phosphate (S1P)1,4,5 receptor modulator for the treatment of moderately to severely active ulcerative colitis and in development for the treatment of immune‐mediated inflammatory diseases. Interaction between S1P and its five recepto...

Full description

Saved in:
Bibliographic Details
Main Authors: Ibragim Gaidarov, H. Kiyomi Komori, Dariusz T. Stepniak, Karin Bruinsma, Huong Dang, Xiaohua Chen, Todd Anthony, Joel Gatlin, Lisa Karimi‐Naser, Anh‐Tuan Ton, Tim Indersmitten, Paul E. Miller, Andre Ghetti, Najah Abi‐Gerges, David Unett, Hussien Al‐Shamma, Christopher J. Rabbat, Catherine Crosby, John W. Adams
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:FEBS Open Bio
Subjects:
etrasimod
pharmacodynamics
pharmacokinetics
sphingosine 1‐phosphate receptor modulator
Online Access:https://doi.org/10.1002/2211-5463.13907
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/2211-5463.13907

Similar Items